MEDICINOVA, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MEDICINOVA, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2021-03-31 was $6.11K, a 2.30% decline year-over-year.
- MEDICINOVA, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2020-09-30 was $5.45K, a 47.64% decline year-over-year.
- MEDICINOVA, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2020-03-31 was $6.25K, a 63.00% decline year-over-year.
- MEDICINOVA, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2019-09-30 was $10.42K, a 54.92% decline year-over-year.
- MEDICINOVA, INC. stock issued during period, value, employee stock purchase plan for fiscal 2021 was $6.11K, a 47.81% decline from fiscal 2020.
- MEDICINOVA, INC. stock issued during period, value, employee stock purchase plan for fiscal 2020 was $11.71K, a 57.14% decline from fiscal 2019.
- MEDICINOVA, INC. stock issued during period, value, employee stock purchase plan for fiscal 2019 was $27.32K, a 46.44% decline from fiscal 2018.
- MEDICINOVA, INC. stock issued during period, value, employee stock purchase plan for fiscal 2018 was $51.01K, a 34.03% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2021-12-31 | $6.11K 10-K/A · filed 2023-03-28 | |
| 2021-03-31 | $6.11K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $11.71K 10-K · filed 2022-02-16 | |
| 2020-09-30 | $5.45K 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $6.25K 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $27.32K 10-K · filed 2021-02-19 | |
| 2019-09-30 | $10.42K 10-Q · filed 2020-10-26 | |
| 2019-03-31 | $16.90K 10-Q · filed 2020-10-26 | $40.01K derived: sum of 4 quarters · filed 2020-10-26 |
| 2018-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $51.01K 10-K · filed 2020-02-13 |
| 2018-09-30 | $23.11K 10-Q · filed 2019-10-24 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-23 | |
| 2018-03-31 | $27.90K 10-Q · filed 2019-10-24 | |
| 2017-12-31 | $77.32K 10-K · filed 2019-02-13 | |
| 2016-12-31 | $87.73K 10-K · filed 2019-02-13 | |
| 2015-12-31 | $89.91K 10-K · filed 2018-02-13 | |
| 2014-12-31 | $60.46K 10-K · filed 2017-02-14 | |
| 2013-12-31 | $56.49K 10-K · filed 2015-03-12 | |
| 2012-12-31 | $58.62K 10-K · filed 2014-03-27 | |
| 2011-12-31 | $8.23K 10-K · filed 2013-03-28 | |
| 2010-12-31 | $37.46K 10-K · filed 2013-03-28 | |
| 2009-12-31 | $81.97K 10-K · filed 2013-03-28 | |
| 2008-12-31 | $86.73K 10-K · filed 2013-03-28 | |
| 2007-12-31 | $33.78K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |